The Charles Drew Program in Missouri: A description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease

Immunohematology

Volumn 22, Issue 3, 2006, Pages 112-116

  Isaak, E J ^a   LeChien, B ^a   Lindsey, T ^b   DeBaun, M R ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN;

BLOOD BANK; BLOOD DONOR; BLOOD GROUP TYPING; CLINICAL PROTOCOL; ERYTHROCYTE TRANSFUSION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; UNITED STATES; UNIVERSITY HOSPITAL;

ANEMIA, SICKLE CELL; AUTOANTIBODIES; BLOOD BANKS; BLOOD DONORS; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; ERYTHROCYTES; HOSPITALS; HUMANS; MISSOURI;

EID: 33750431740     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1988;339:5-11.
2. Vichinsky EP, Luban NLC, Wright E et al. Prospective RBC phenotyping in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
3. Osby M, Shulman IA. Phenotypic matching of donor red blood cell units for nonalloimmunized sickle cell disease patients. Arch Pathol Lab Med 2005;129:190-3.
4. Castro O, Sandler SG, Houston-Yu P, and Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
5. Mowbray JF, Gibbings C, Liddel H, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985;1:941-3.
6. Klein HG. Immunologic aspects of blood transfusion. Semin Oncol 1994;21:16-20.
7. Waanders MM, Roelen DL, Brand A, Claas FHJ. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Trans Med Rev 2005;19(4):281-7.
8. Persijn GG, Cohen B, Lansbergen Q, et al. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in the Netherlands. Transplantation 1979;28:396-401.